Abstract
The realization of the therapeutic potential of monoclonal antibodies will depend on the efficient generation and maintenance of hybridomas. At a recent workshop on the Stability and Viability of Antibody-Producing Cell Lines it was clear that there are still large gaps in the knowledge needed to achieve that aim.
Original language | English (US) |
---|---|
Pages (from-to) | 257-258 |
Number of pages | 2 |
Journal | Immunology today |
Volume | 8 |
Issue number | 9 |
DOIs | |
State | Published - 1987 |
Externally published | Yes |
ASJC Scopus subject areas
- Immunology